Cargando…

A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors

OBJECTIVES: To retrospectively determine the extent and types of adverse drug events (ADEs) from the patient cases sheets and identify the contributing factors of medication errors. To assess causality and severity using the World Health Organization (WHO) probability scale and Hartwig's scale,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sam, Aaseer Thamby, Lian Jessica, Looi Li, Parasuraman, Subramani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357002/
https://www.ncbi.nlm.nih.gov/pubmed/25767366
http://dx.doi.org/10.4103/0976-0105.152095
_version_ 1782361072287612928
author Sam, Aaseer Thamby
Lian Jessica, Looi Li
Parasuraman, Subramani
author_facet Sam, Aaseer Thamby
Lian Jessica, Looi Li
Parasuraman, Subramani
author_sort Sam, Aaseer Thamby
collection PubMed
description OBJECTIVES: To retrospectively determine the extent and types of adverse drug events (ADEs) from the patient cases sheets and identify the contributing factors of medication errors. To assess causality and severity using the World Health Organization (WHO) probability scale and Hartwig's scale, respectively. METHODS: Hundred patient case sheets were randomly selected, modified version of the Institute for Healthcare Improvement (IHI) Global Trigger Tool was utilized to identify the ADEs; causality and severity were calculated utilizing the WHO probability scale and Hartwig's severity assessment scale, respectively. RESULTS: In total, 153 adverse events (AEs) were identified using the IHI Global Trigger Tool. Majority of the AEs are due to medication errors (46.41%) followed by 60 adverse drug reactions (ADRs), 15 therapeutic failure incidents, and 7 over-dose cases. Out of the 153 AEs, 60 are due to ADRs such as rashes, nausea, and vomiting. Therapeutic failure contributes 9.80% of the AEs, while overdose contributes to 4.58% of the total 153 AEs. Using the trigger tools, we were able to detect 45 positive triggers in 36 patient records. Among it, 19 AEs were identified in 15 patient records. The percentage of AE/100 patients is 17%. The average ADEs/1000 doses is 2.03% (calculated). CONCLUSION: The IHI Global Trigger Tool is an effective method to aid provisionally-registered pharmacists to identify ADEs quicker.
format Online
Article
Text
id pubmed-4357002
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43570022015-03-12 A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors Sam, Aaseer Thamby Lian Jessica, Looi Li Parasuraman, Subramani J Basic Clin Pharm Original Article OBJECTIVES: To retrospectively determine the extent and types of adverse drug events (ADEs) from the patient cases sheets and identify the contributing factors of medication errors. To assess causality and severity using the World Health Organization (WHO) probability scale and Hartwig's scale, respectively. METHODS: Hundred patient case sheets were randomly selected, modified version of the Institute for Healthcare Improvement (IHI) Global Trigger Tool was utilized to identify the ADEs; causality and severity were calculated utilizing the WHO probability scale and Hartwig's severity assessment scale, respectively. RESULTS: In total, 153 adverse events (AEs) were identified using the IHI Global Trigger Tool. Majority of the AEs are due to medication errors (46.41%) followed by 60 adverse drug reactions (ADRs), 15 therapeutic failure incidents, and 7 over-dose cases. Out of the 153 AEs, 60 are due to ADRs such as rashes, nausea, and vomiting. Therapeutic failure contributes 9.80% of the AEs, while overdose contributes to 4.58% of the total 153 AEs. Using the trigger tools, we were able to detect 45 positive triggers in 36 patient records. Among it, 19 AEs were identified in 15 patient records. The percentage of AE/100 patients is 17%. The average ADEs/1000 doses is 2.03% (calculated). CONCLUSION: The IHI Global Trigger Tool is an effective method to aid provisionally-registered pharmacists to identify ADEs quicker. Medknow Publications & Media Pvt Ltd 2015-03 /pmc/articles/PMC4357002/ /pubmed/25767366 http://dx.doi.org/10.4103/0976-0105.152095 Text en Copyright: © Journal of Basic and Clinical Pharmacy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sam, Aaseer Thamby
Lian Jessica, Looi Li
Parasuraman, Subramani
A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
title A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
title_full A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
title_fullStr A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
title_full_unstemmed A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
title_short A retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
title_sort retrospective study on the incidences of adverse drug events and analysis of the contributing trigger factors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357002/
https://www.ncbi.nlm.nih.gov/pubmed/25767366
http://dx.doi.org/10.4103/0976-0105.152095
work_keys_str_mv AT samaaseerthamby aretrospectivestudyontheincidencesofadversedrugeventsandanalysisofthecontributingtriggerfactors
AT lianjessicalooili aretrospectivestudyontheincidencesofadversedrugeventsandanalysisofthecontributingtriggerfactors
AT parasuramansubramani aretrospectivestudyontheincidencesofadversedrugeventsandanalysisofthecontributingtriggerfactors
AT samaaseerthamby retrospectivestudyontheincidencesofadversedrugeventsandanalysisofthecontributingtriggerfactors
AT lianjessicalooili retrospectivestudyontheincidencesofadversedrugeventsandanalysisofthecontributingtriggerfactors
AT parasuramansubramani retrospectivestudyontheincidencesofadversedrugeventsandanalysisofthecontributingtriggerfactors